Tau-PET imaging enables the visualization and measurement of tau load in the brain, offering insights into the distribution and impact of tau pathology with respect to PD patients [46] (Figure 2 and Figure 3, Table 1). This evidence concerns the gene MAPT and Parkinson disease.